Validated GC-MS analysis for the determination of residual fentanyl in applied Durogesic® reservoir and Durogesic® D-Trans® matrix transdermal fentanyl patches

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 846, Issue 1-2, 2007, Pages 264-272

  Van Nimmen, Nadine F J ^a   Veulemans, Hendrik A F ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Fentanyl; GC MS; Matrix type; Method validation; Reservoir type; Transdermal patch

Indexed keywords

FENTANYL; FENTANYL EXTRACTION; GC-MS; MATRIX TYPES; METHOD VALIDATION; RESERVOIR TYPES; TRANSDERMAL PATCH; TRANSDERMAL THERAPEUTIC SYSTEM (TTS);

BIOASSAY; CHROMATOGRAPHIC ANALYSIS; DRUG DOSAGE; EXTRACTION; MASS SPECTROMETRY; PATIENT MONITORING;

GAS CHROMATOGRAPHY;

DEUTERIUM; DUROGESIC D TRANS; FENTANYL; METHANOL; UNCLASSIFIED DRUG;

ACCURACY; ANALYTICAL ERROR; ARTICLE; CANCER PATIENT; DRUG DETERMINATION; DRUG ISOLATION; GAS CHROMATOGRAPHY; HUMAN; ION MONITORING; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; TRANSDERMAL PATCH; VALIDATION PROCESS;

ADMINISTRATION, CUTANEOUS; ANALGESICS, OPIOID; DOSAGE FORMS; DRUG RESIDUES; FENTANYL; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS;

EID: 33846412279     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2006.09.002     Document Type: Article

References (13)

1. Larsen R.H., Nielsen F., Sorensen J.A., and Nielsen J.B. Pharmacol. Toxicol. 93 (2003) 244
2. Grond S., Radbruch L., and Lehmann K.A. Clin. Pharmacokinet. 38 1 (2000) 59
3. Muijsers R.B.R., and Wagstaff A.J. Drugs 61 (2001) 2289
4. Kornick C.A., Santiago-Palma J., Moryl N., Payne R., and Obbens E.A.M.T. Drug Saf. 26 (2003) 951
5. Johnson & Johnson, 2004 Annual Report, Consulted September 2005, available at http://www.jnj.com/2004AnnualReport.
6. Freynhagen R., von Giesen H.J., Busche P., Sabatowski R., Konrad Ch., and Grond S. J. Pain Sympt. Manage. 30 (2005) 289
7. Alza Corporation, Duragesic Fentanyl Transdermal System, Instruction Leaflet, Mountain View, USA, Revised May 2003.
8. Karst M., Fink M., Wagner T., and Conrad I. Pain Med. 2 (2001) 225
9. Solassol I., Bressolle F., Caumette L., Garcia F., Poujol S., Culine S., and Pinguet F. Ther. Drug Monit. 27 (2005) 491
10. Varvel J.R., Shafer S.L., Hwang S.S., Coen P.A., and Stanski D.R. Anesthesiology 70 (1989) 928
11. Portenoy R.K., Southam M.A., Gupta S.K., Lapin J., Layman M., Inturrisi C.E., and Foley K.M. Anesthesiology 78 (1993) 36
12. Marquardt K.A., Tharratt R.S., and Musallam N.A. Ann. Pharmacother. 29 (1995) 969
13. Solassol I., Caumette L., Bressolle F., Garcia F., Thézenas S., Astre C., Culine S., Coulouma R., and Pinguet F. Oncol. Rep. 14 (2005) 1029